Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-12

Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Rodney J. Hunter, Jooyoung Park, Kristen J. Asprer [...]

Journal of Pharmacy Technology

Open access

Review article

First published 2017-5

Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy

Paule Augereau, Anne Patsouris, Emmanuelle Bourbouloux [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Sijia Wu, Junnan Xu, Yiwen Ma [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2026

CDK4/6 inhibitors in invasive lobular carcinoma: Efficacy,resistance patterns,and endocrine partners

Saim Mahmood Khan, Aroobah Jawwad, Maheen Kashif [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2025

Understanding and overcoming CDK4/6 inhibitor resistance in HR+/HER2− metastatic breast cancer: clinical and molecular perspectives

Jessé Lopes da Silva, Leandro Jonata de Carvalho Oliveira, Cristiano Augusto Andrade de Resende [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2017-2

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Andrea Rocca, Alessio Schirone, Roberta Maltoni [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2023

Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer

Mark Pegram, Richard Pietras, Chau T. Dang [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2019

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer

Emilia Montagna, Marco Colleoni

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2019

HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Sonia Pernas, Sara M. Tolaney

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role

Maxwell R. Lloyd, Seth A. Wander, Erika Hamilton [...]

Therapeutic Advances in Medical Oncology

Search results